A
Alida Biosciences
Pioneering next-generation epigenetic analysis technology for advanced research, therapeutics, and diagnostics
About Alida Biosciences
Alida Bio is a biotechnology startup that operates in the field of gene regulation. The company focuses on understanding the complex relationships in gene regulation, specifically the role of epigenetic markers, which include modifications of DNA, RNA, and histone proteins. These markers play a crucial role in controlling how the genetic code is used in health and disease. Alida Bio's technology is unique in that it can detect and locate many epigenetic markers at once, unlike current methods that can only detect one at a time.
The company's work has significant implications for drug development, particularly in the field of cancer treatment. Alida Bio is exploring new drug targets, including RNA modification writers, erasers, and readers, which are becoming important cancer drug targets. The company is also involved in therapeutic RNA editing, which is gaining traction as a potentially safer alternative to DNA editing methods like CRISPR.
Alida Bio's technology is also valuable for basic and clinical research. By identifying and locating RNA modifications, researchers can gain a better understanding of systems biology and disease mechanisms. This could lead to the development of new diagnostics and treatment regimes.
The company's business model involves providing assays, or tests, that can study RNA modifications. These assays can save researchers time and reduce variability in their experiments. Alida Bio also offers a proprietary analysis pipeline that can interpret complex genomics data, accessible via cloud or as a desktop application.
Alida Bio's revenue comes from selling their assays and analysis software to researchers and pharmaceutical companies. They also offer partnerships for early access to their technology, providing tailored support from their experienced team.
Source: Dealroom company dataAt a glance
- Founded
- 2020
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
News
Open roles
Alida Biosciences in the San Diego ecosystem
The Alida Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Human Genome Research Institute
Series A3 investors entered at this stage
Genoa Ventures
FusionX Ventures
Vertical Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Alida Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Alida Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

